Varicella vaccine cost-effective: US study

Comeau, Pauline
November 2004
CMAJ: Canadian Medical Association Journal;11/9/2004, Vol. 171 Issue 10, p1161
Academic Journal
Focuses on the results of a study in the U.S. about the impact of varicella vaccination on direct medical costs. Rate of decline in hospital admissions of children affected by chickenpox between 1995 and 2001; Percentage of increase in children's vaccinations in the country in 2004; Information on varicella immunization programs in Canada.


Related Articles

  • Varicella vaccination cost saving in Germany and France.  // PharmacoEconomics & Outcomes News;6/18/2005, Issue 480, p14 

    Discusses research being done on the cost effectiveness of a routine childhood varicella vaccination programme in France and Germany. Reference to a study by L. Coudeville, A. Brunot et al, published in the May to June 2005 issue of the periodical "Value in Health"; Model used to assess the...

  • Targeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination. Bruijning-Verhagen, Patricia; Mangen, Marie-Josée J.; Felderhof, Mariet; Hartwig, Nico G.; Van Houten, Marlies; Winkel, Léon; De Waal, Wouter J.; Bonten, Marc J. M. // BMC Medicine;2013, Vol. 11 Issue 1, p1 

    Background: The cost-effectiveness of universal rotavirus (RV) vaccination is controversial in developed countries. As a result, RV vaccination programs do not currently exist in most European countries. Hospitalization is the main driver of RV disease costs, and prematurity, low birth weight...

  • Incidence and Cost of Rotavirus Hospitalizations in Denmark. Fischer, Thea Kølsen; Nielsen, Nete Munk; Wohlfahrt, Jan; Pærregaard, Anders // Emerging Infectious Diseases;Jun2007, Vol. 13 Issue 6, p855 

    In anticipation of licensure and introduction of rotavirus vaccine into the western market, we used modeling of national hospital registry data to determine the incidence and direct medical costs of annual rotavirus-associated admissions over >11 years in Denmark. Diarrhea-associated...

  • Update.  // Medical Marketing & Media;May2010, Vol. 45 Issue 5, p9 

    The article offers news briefs related to the pharmaceutical industry including Lechleiter's shift on healthcare reform from cost to an understanding of value, Pfizer Inc. will supply its Prevnar 13 pediatric vaccine to deprived countries, and the threat of increasing healthcare costs.

  • Clinical Manifestations of Pertussis in Pediatrics Admitted to Sari Boalisina Hospital, 2008-2012. Bahari, Milad; sadeghian, Iman; Rezai, Mohammadsadegh; Ghorbani, Gholamreza // Journal of Mazandaran University of Medical Sciences (JMUMS);Jun2013, Vol. 23 Issue 101, p1 

    Background and purpose: Pertussis is one of the communicable reasons of prolonged cough that children are being vaccinated in our country for prophylaxis. Despite high vaccine coverage the incidence of pertussis is still increasing. This study was done to investigate the prevalence of pertussis...

  • Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland. Patrzałek, M.; Albrecht, P.; Sobczynski, M. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2010, Vol. 29 Issue 7, p787 

    This study was performed to estimate the effect of heptavalent pneumococcal conjugate vaccine (PCV7) on the pneumonia admission rate in children younger than 5 years of age, after the introduction of routine 2+1 dose schedule immunization. We compared the pneumonia admission rate (number of...

  • Growing burden of hospital costs in the US.  // PharmacoEconomics & Outcomes News;Nov2013, Issue 691, p5 

    The article offers medical related news briefs in the U.S. on the data from the Healthcare Cost and Utilization Project indicating that the aggregate cost for about 93 million hospital stays in 2011 totalled $387.2 billion and septicemia as the most expensive condition treated in the hospitals.

  • CMS Implements Special Add-On Payments for New Technologies.  // hfm (Healthcare Financial Management);Feb2003, Vol. 57 Issue 2, p10 

    Reports on the provision of the final rule implementing provisions of the Benefits Improvement and Protection Act of 2000, that add-on payments be made for discharges involving approved technologies, if the total costs of the discharge exceed the DRG payment for the case. Terms of the payment...

  • Determinants of vaccination coverage and adherence to the Greek national immunization program among infants aged 2-24 months at the beginning of the economic crisis (2009-2011). Vassiliki, Papaevangelou; Ioanna, Koutsoumbari; Artemis, Vintila; Eleni, Klinaki; Aglaia, Zellos; Attilakos, Achilleas; Maria, Tsolia; Dimitris, Kafetzis // BMC Public Health;2014, Vol. 14 Issue 1, p1 

    Background Childhood immunization has significantly reduced the incidence of vaccine preventable diseases. Parental mistrust over vaccine safety has been associated with vaccine refusal creating barriers on vaccine coverage. Recently, economic crisis has imposed additional impediment. Methods...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics